PROTECT AKTIENANLEIHE - PFIZER INC Share Price

Certificat

DE000VU8KDP2

Market Closed - Deutsche Boerse AG 18:50:34 10/05/2024 BST
93.83 USD 0.00% Intraday chart for PROTECT AKTIENANLEIHE - PFIZER INC
Current month+15.88%
1 month+9.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
10/05/24 93.83 0.00% 0
09/05/24 93.83 +0.76% 0
08/05/24 93.12 +2.18% 0
07/05/24 91.13 -0.69% 0
06/05/24 91.76 +2.06% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 06:50 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU8KDP
ISINDE000VU8KDP2
Date issued 15/06/2023
Strike 39 $
Maturity 20/12/2024 (224 Days)
Parity 0.04 : 1
Emission price 100 $
Emission volume N/A
Settlement both
Currency USD

Technical Indicators

Highest since issue 99.33 $
Lowest since issue 78.76 $

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.18 USD
Average target price
31.94 USD
Spread / Average Target
+13.34%
Consensus